BOZIC CARMEN 1790029 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-07 | 2023-09-05 | 2023-09-05 | 4 | Bozic Carmen | EVP AND CMO | dsp | 5651.0 | 8.94 | 0.22 | 352.66 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 57556.0 | 258.09 (VRTX) |
| 2023-09-21 | 2023-09-19 | 2023-09-19 | 4 | Bozic Carmen | EVP AND CMO | dsp | 5651.0 | 9.82 | 0.22 | 351.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 51905.0 | 258.09 (VRTX) |
| 2023-10-05 | 2023-10-03 | 2023-10-03 | 4 | Bozic Carmen | EVP AND CMO | dsp | 5651.0 | 10.89 | 0.22 | 345.28 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 46254.0 | 258.09 (VRTX) |
| 2023-10-19 | 2023-10-17 | 2023-10-17 | 4 | Bozic Carmen | EVP AND CMO | dsp | 5651.0 | 12.22 | 0.22 | 373.25 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 40603.0 | 258.09 (VRTX) |
| 2023-11-02 | 2023-10-31 | 2023-10-31 | 4 | Bozic Carmen | EVP AND CMO | dsp | 5651.0 | 13.92 | 0.22 | 355.92 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 34952.0 | 258.09 (VRTX) |
| 2023-11-16 | 2023-11-14 | 2023-11-14 | 4 | Bozic Carmen | EVP AND CMO | dsp | 5650.0 | 16.17 | 0.22 | 380.82 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 29302.0 | 257.68 (VRTX) |
| 2024-02-08 | 2024-02-06 | 2024-02-06 to 2024-02-07 | 4 | Bozic Carmen | EVP AND CMO | acq | 19608.0 | 40.09 | 0.76 | 0.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code A | 48910.0
|
257.68 (VRTX) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Bozic Carmen | EVP AND CMO | dsp | 2100.0 | 4.29 | 0.08 | 422.74 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F | 46810.0 | 257.68 (VRTX) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 to 2024-02-20 | 4 | Bozic Carmen | EVP AND CMO | dsp | 6562.0 | 14.02 | 0.25 | 422.54 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F | 40248.0
|
258.31 (VRTX) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 | 4 | Bozic Carmen | EVP AND CMO | dsp | 3309.0 | 8.22 | 0.13 | 431.79 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F | 36939.0 | 258.31 (VRTX) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)